NutraFuels Inc., CBD Nutraceutical Manufacturer, to launch CBD Twists and CBD Drink Shots Single-Dose Options for Consumers
Coconut Creek, FL, Oct 05, 2018 - (ACN Newswire) - NutraFuels nutraceutical line of Cannabidiol (CBD) products, branded under the brand name NutraHempCBD, prepares for the launch of two travel-size additions to its line of hemp-infused products. New to its CBD line, NutraFuels is adding single-dose options to its offerings in the form of easy-open CBD Twists and CBD Drink Shots. The grab-and-go options round out a robust product portfolio made up of face cream, pain and joint balm, oral sprays, pet supplements, and tinctures.
"These are true impulse buys to make single-serving of CBD affordable," said Edgar Ward, CEO and President of NutraFuels Inc. "This is an evolution of our CBD line that is consistent with our dedication to utilizing high bioavailable liquid delivery systems to deliver the CBD nutrient to the body efficiently and effectively."
The CBD Twists will come in five formulations; Energy, Stress, Weight, Pain, and Sleep. The easy-open twist-offs will be sold individually. This container offers a daily 5 milligram single-serving of CBD for health and wellness for everyday use. The 2-ounce CBD drink shot will come in various flavors and consumers will have the option to take an energy shot with CBD, a sleep shot with CBD, or a pure 25mg CBD shot for wellness.
These CBD products are being produced for retail distribution across the country as experts forecast a successful financial future for those in the hemp industry. As FOX17 News reported from the Hemp Expo, hemp came back to Tennessee four years ago and experts believe it could turn into one of the state's biggest cash crops.
"We attended the Southern Hemp Expo and had a great response to our products," said Chloe Sommers, spokesperson for NutraFuels. "The most experienced in the hemp industry were excited about our product."
From farm to finished goods, NutraFuels' products adhere to high manufacturing standards throughout every step of the process. The US-based manufacturing facility is held to GMP standards. The alternative delivery systems used for NutraFuels' products are recognized convenience, dosage precision, and timely assimilation into the body.
"It was extraordinary to have CBD industry leaders from across the country, like Florida's NutraHempCBD, in Nashville for the Southern Hemp Expo," said Rick Trojan, Vice President of the Hemp Industry Association and emcee of the hemp expo. "It's a testament to the increasing awareness of the health benefits and industrial use of the plant."
CBD Twists and CBD Drink Shots are being manufactured by NutraHempCBD for the retail marketplace. It offers a single serving of CBD plus other clinically tested ingredients for daily health and wellness applications. NutraFuels' goal is to have these new products in the marketplace by the end of the year.
"Through our nationwide distribution to retail outlets these two new products offer consumers an alternative to buying a bottle of CBD, which can go for more than $100," added Ward. "It's compact and convenient for consumers and retailers - a retail checkout point of sale when there isn't much in the way of single serving for CBD."
NutraFuels is a fully reporting company with a class of securities registered with the SEC. The Company's filings can be viewed at www.sec.gov. NTFU's CBD products and information about the company's direct sales program can be found online at http://www.nutrafuels.com/ and www.nutrahempcbd.com Forward Looking Statements This communication contains statements of a forward-looking nature. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. You can identify these forward-looking statements by words or phrases such as "may," "will," "except," "anticipate," "aim," "estimate," "intend," "plan," "believe," "is/are likely to," "future" or other similar expressions. The Company has based these forward-looking statements largely on the Company's current expectations and projections about future events and financial trends that the Company believes may affect Company's financial condition, results of operations, business strategy and financial needs. There is no assurance that Company's current expectations and projections are accurate. All forward-looking statements in this press release are based on information available to the Company on the date hereof. These statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to differ materially from those implied by the forward-looking statements. More detailed information about these risk factors are set forth in the Company's filings with the Securities and Exchange Commission, including, but not limited to, those risks and uncertainties listed in the section entitled "Risk Factors," in the Company's Annual Report on Form 10-K with the Securities and Exchange Commission on April 17, 2018. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company's management to predict all risk factors, nor can the Company assess the impact of all factors on Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement. The Company does not undertake any obligation to update or revise the forward-looking statements except as required under applicable law. investors@nutrafuels.com
Source: NutraLife Biosciences, Inc. Sectors: Healthcare & Pharm
Copyright ©2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
Latest Release
 Toni Bou Wins 19th Consecutive FIM Trial World Championship Title Sep 08, 2025 18:53 JST
|  Eisai Presents Clinical Study Results of Novel Orexin Receptor Agonist E2086 for Narcolepsy at World Sleep 2025 Sep 08, 2025 17:49 JST
|  Honda to Commercialize UNI-ONE Hands-Free Personal Mobility Device Sep 08, 2025 15:56 JST
|  Mitsubishi Power Signs Contract to Supply Two M701JAC Gas Turbines to O Mon 4 Power Plant Sep 08, 2025 15:36 JST
|  Fujitsu develops generative AI reconstruction technology for optimized and energy-efficient AI models based on Takane LLM Sep 08, 2025 14:28 JST
|  10th anniversary CENTRESTAGE concludes successfully Sep 06, 2025 21:36 JST
|  Mitsubishi Power Receives Contract for Large-Scale GTCC Project with 2,800 MW Total Output for Taiwan's Tung Hsiao Power Plant Sep 05, 2025 21:47 JST
|  Hitachi announces historic $1 billion USD manufacturing investment to power America's energy future through production of critical grid infrastructure Sep 05, 2025 21:00 JST
|  NEC participates in Locked Shields 2025 hosted by the NATO Cooperative Cyber Defence Centre of Excellence Sep 05, 2025 11:20 JST
|  TANAKA Announces Executive Appointment Sep 05, 2025 03:00 JST
|  Honda to Begin Sales of All-new Prelude Sep 04, 2025 13:20 JST
|  Signing of Agreement with Yamaguchi Prefecture and Iwakuni City to Construct Module Pack Plant of Automotive Cylindrical Lithium-Ion Batteries Sep 04, 2025 11:54 JST
|  NEC to begin proof of concept for early earthquake detection and analysis in Colombia Sep 04, 2025 11:15 JST
|  Eisai to Present Latest Data on Lemborexant and Novel Orexin Receptor Agonist E2086 at The World Sleep 2025 Sep 04, 2025 10:56 JST
|  Honda Premieres a New Color Option for Four Large-size Outboard Motors at HISWA In-Water Boat Show 2025 in the Netherlands Sep 03, 2025 23:50 JST
|  Toyota Joins TOKYO H2 Project Aiming to Make Tokyo a Global Leader in Hydrogen Sep 03, 2025 22:39 JST
|  Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event Sep 03, 2025 12:30 JST
|  Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status Sep 03, 2025 11:32 JST
|  Anime Tokyo Station: TV Anime "SPY x FAMILY" Special Exhibition, Period: August 16 - November 9, 2025 Sep 03, 2025 11:00 JST
|  Fujitsu, 1Finity and Arrcus sign strategic partnership agreement to deliver innovative network solutions for AI infrastructure Sep 03, 2025 10:58 JST
|
More Latest Release >>
|